Epidemiological trends and cross-country inequalities in the global burden of Alzheimer's disease and other dementias in postmenopausal women from 1990 to 2021
Ageing Research Reviews · 2026-05 · 117 · 103069
DOI: 10.1016/j.arr.2026.103069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-05. Verfasst von Junmiao Ge und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Postmenopause, Dementia, Global Health. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
OBJECTIVE: To evaluate the trends, cross-country inequalities, and risk factors associated with Alzheimer's disease and other dementias (ADOD) in postmenopausal women globally, and project the disease burden to 2050. METHODS: The age-standardized rates (ASRs) and 95% uncertainty intervals (UIs) of prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) for ADOD among postmenopausal women were estimated by using the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021 data. The average annual percentage change (AAPC) was calculated using joinpoint regression. A decomposition analysis was performed to quantify the contributions of population growth, aging, and epidemiologic changes. The slope index of inequality (SII) and concentration index, as recommended by the World Health Organization, were used to evaluate the cross-country inequalities in ADOD burden. The ADOD burden among postmenopausal women to 2050 was projected using the Bayesian age-period-cohort analysis (BAPC) model. Risk factor attribution was quantified according to GBD methodology. RESULTS: In 2021, the estimated global ASRs of prevalence, incidence, mortality, and DALYs of ADOD among postmenopausal women were 4414.52 (95%UIs: 3492.78, 5504.77), 751.18 (95%UIs: 517.67, 1019.3), 164.29 (95%UIs: 41.79, 425.37), and 2935.7 (95%UIs: 1349.85, 6306.48) per 100,000 population, respectively. East Asia recorded the highest total number of cases and the highest ASRs of prevalence and incidence, while Central Sub-Saharan Africa showed the highest ASRs of mortality and DALYs. From 1990-2021, the ADOD burden increased most rapidly during 2019-2021. Population growth (82.07% contribution) and aging (12.48%) were the primary drivers of increases in global DALYs. SDI-related inequalities escalated over time, with the SII increasing from 1275.06 [95% confidence interval (CI): 1037.55, 1512.57] in 1990 to 1697.71 (95%CI: 1430.70, 1964.73) in 2021. The BAPC model showed that both the ASRs and case number of prevalence, incidence, mortality, and DALYs were predicted to increase from 2022 to 2050, with predicted ASRs of 6067.51 [95% credible interval (CrI): 2149.42, 9985.60], 1052.37 (95%CrI: 361.2, 1743.54), 186.15 (95%CrI: 90.01, 282.3), and 3602.34 (95%CrI: 1530.01, 5674.67) per 100,000 population in 2050. High fasting plasma glucose was identified as the leading risk factor contributing to ADOD burden. CONCLUSIONS: From 1990 to 2021, there was an overall upward trend in the global burden of ADOD among postmenopausal women. Driven by demographic shifts (population growth and aging) and metabolic risks (particularly high fasting plasma glucose), the burden of postmenopausal women with ADOD is expected to increase substantially. Postmenopausal women in higher SDI countries bore a disproportionately higher ADOD burden, and the SDI-related inequalities among countries widened during the study period. These findings highlight major challenges in the prevention, control, and management of ADOD in postmenopausal women. Health authorities should shift from reactive treatments to proactive prevention, emphasizing the establishment of targeted health policies, glucose control, and optimizing medical resource allocation to meet the heterogeneous needs of this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
- Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: yuekangyi@fmmu.edu.cn.
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: jdsun120@163.com.
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: pengluo@fmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ge, J., Ge, J., Bao, M., Zhang, L., Li, K., Ji, A., Mao, X., Jiang, X., Yue, K., Sun, J., & Luo, P. (2026). Epidemiological trends and cross-country inequalities in the global burden of Alzheimer's disease and other dementias in postmenopausal women from 1990 to 2021. Ageing Research Reviews, 117, 103069. https://doi.org/10.1016/j.arr.2026.103069
Vancouver
Ge J, Ge J, Bao M, Zhang L, Li K, Ji A, et al. Epidemiological trends and cross-country inequalities in the global burden of Alzheimer's disease and other dementias in postmenopausal women from 1990 to 2021. Ageing Research Reviews. 2026;117:103069. doi:10.1016/j.arr.2026.103069
BibTeX
@article{Ge2026,
author = {Ge, Junmiao and Ge, Junli and Bao, Mingdong and Zhang, Lei and Li, Ke and Ji, Ang and Mao, Xinggang and Jiang, Xiaofan and Yue, Kangyi and Sun, Jidong and Luo, Peng},
title = {Epidemiological trends and cross-country inequalities in the global burden of Alzheimer's disease and other dementias in postmenopausal women from 1990 to 2021},
journal = {Ageing Research Reviews},
year = {2026},
volume = {117},
pages = {103069},
doi = {10.1016/j.arr.2026.103069}
}
EUVIMED